CEREVEL THERAPEUTICS HLDNG I's ticker is and the CUSIP is 15678U958. A total of 4 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $960,520 | -4.1% | 44,000 | +39.7% | 0.00% | – |
| Q2 2023 | $1,001,385 | -24.1% | 31,500 | -41.8% | 0.00% | -100.0% |
| Q1 2023 | $1,319,499 | -38.8% | 54,100 | -20.9% | 0.00% | 0.0% |
| Q4 2022 | $2,157,336 | +53.5% | 68,400 | +37.6% | 0.00% | 0.0% |
| Q3 2022 | $1,405,000 | +203.5% | 49,700 | +184.0% | 0.00% | – |
| Q2 2022 | $463,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 42,700 | $1,346,758 | 0.00% |
| JANE STREET GROUP, LLC | 68,400 | $2,157,336 | 0.00% |
| SIMPLEX TRADING, LLC | 4,400 | $138 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |